(Q35661244)

9 August 2017

title

Pulmonary disease in systemic lupus erythematosus and the antiphospholpid syndrome (English)

1 reference

systemic lupus erythematosus

9 August 2017

1 reference

1 reference

Daphna Paran

1

1 reference

9 August 2017

Elizabeth Fireman

series ordinal

2

1 reference

9 August 2017

Ori Elkayam

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

3

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

70-75

1 reference

Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

The role of thrombosis in severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

The lung in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Novel therapeutic agents for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

How to manage patients with cardiopulmonary disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Pulmonary diffusion capacity in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Functional asplenia in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Diagnostic approach to the patient with diffuse lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Pulmonary hypertension in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Fibroblast growth factors in connective tissue disease associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

Lung Function Disturbances versus Respiratory Muscle Fatigue in Patients with Systemic Lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2803%2900090-9

7 January 2021

10.1016/S1568-9972(03)00090-9

Identifiers

DOI

1 reference

9 August 2017

1 reference